(Q52921224)

9 May 2018

title

Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study. (English)

1 reference

9 May 2018

1 reference

1 reference

Peter Bräunig

1

1 reference

9 May 2018

Emilio Sacchetti

series ordinal

2

1 reference

9 May 2018

Rossella Medori

series ordinal

3

1 reference

9 May 2018

publication date

1 January 2008

1 reference

9 May 2018

International Journal of Psychiatry in Clinical Practice

published in

1 reference

9 May 2018

volume

12

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

74-77

1 reference

9 May 2018

Antipsychotic drugs in bipolar disorder

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Novel antipsychotics in bipolar and schizoaffective mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

The role of atypical antipsychotics in bipolar depression and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Acute and continuation risperidone monotherapy in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Risperidone in acute and continuation treatment of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Role of risperidone in bipolar II: an open 6-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Risperidone long-acting injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500701538161

10.1080/13651500701538161

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018